Brown, Lisle/Cummings’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$63.4K	Buy	82 +7	+9%	+$5.36K	0.02%	321
2025 Q4	$57.9K	Hold	75	–	–	0.01%	327
2025 Q3	$42.2K	Hold	75	–	–	0.01%	359
2025 Q2	$39.4K	Hold	75	–	–	0.01%	362
2025 Q1	$47.6K	Hold	75	–	–	0.01%	334
2024 Q4	$53.4K	Buy	75 +10	+15%	+$8.39K	0.02%	328
2024 Q3	$68.3K	Hold	65	–	–	0.02%	292
2024 Q2	$68.3K	Buy	65 +10	+18%	+$9.69K	0.02%	284
2024 Q1	$52.9K	Hold	55	–	–	0.02%	287
2023 Q4	$48.3K	Hold	55	–	–	0.02%	288
2023 Q3	$45.3K	Sell	55 -20	-27%	-$15.7K	0.02%	278
2023 Q2	$53.9K	Hold	75	–	–	0.02%	270
2023 Q1	$61.6K	Hold	75	–	–	0.03%	260
2022 Q4	$54.1K	Hold	75	–	–	0.03%	257
2022 Q3	$51.7K	Hold	75	–	–	0.03%	249
2022 Q2	$44.3K	Hold	75	–	–	0.02%	270
2022 Q1	$52.4K	Hold	75	–	–	0.03%	262
2021 Q4	$47.4K	Buy	+75	New	+$46.1K	0.02%	267